We are live on ! Find out more
RCAMU

Rothschild & Co Asset Management US Portfolio holdings

AUM $6.58B
1-Year Est. Return 4.5%
This Fund
S&P 500
This Quarter Est. Return
-0.52%
1 Year Est. Return
-4.5%
3 Year Est. Return
+63.72%
5 Year Est. Return
+103.96%
10 Year Est. Return
AUM
$8.99B
AUM Growth
-$490M
Cap. Flow
-$393M
Cap. Flow %
-4.38%
Top 10 Hldgs %
11.14%
Holding
369
New
24
Increased
60
Reduced
265
Closed
16

Sector Composition

Rank Sector Weight
1 Financials 19.23%
2 Industrials 16.03%
3 Healthcare 13.22%
4 Technology 11.46%
5 Consumer Discretionary 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MXL icon
326
MaxLinear
MXL
$6.26B
$1.57M 0.02%
69,195
-7,631
-10% -$190K
BRX icon
327
Brixmor Property Group
BRX
$9.09B
$1.53M 0.02%
100,453
BEAT
328
DELISTED
BioTelemetry, Inc.
BEAT
$1.52M 0.02%
48,975
-5,375
-10% -$177K
RPXC
329
DELISTED
RPX Corporation
RPXC
$1.51M 0.02%
141,169
-162,696
-54% -$1.99M
HDP
330
DELISTED
Hortonworks, Inc.
HDP
$1.49M 0.02%
+73,063
New +$1.44M
FWRD icon
331
Forward Air
FWRD
$628M
$1.45M 0.02%
27,408
-3,697
-12% -$211K
FOLD
332
DELISTED
Amicus Therapeutics
FOLD
$1.45M 0.02%
96,131
+3,622
+4% +$55.1K
ISBC
333
DELISTED
Investors Bancorp, Inc.
ISBC
$1.39M 0.02%
101,675
-2,114,034
-95% -$29.3M
RVNC
334
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.37M 0.02%
44,478
-4,823
-10% -$155K
ESPR
335
DELISTED
Esperion Therapeutics
ESPR
$1.37M 0.02%
18,919
-1,952
-9% -$143K
UEIC icon
336
Universal Electronics
UEIC
$74.6M
$1.32M 0.01%
25,292
-2,964
-10% -$144K
JBLU icon
337
JetBlue
JBLU
$2.19B
$1.31M 0.01%
64,371
ADC icon
338
Agree Realty
ADC
$9.13B
$1.27M 0.01%
26,382
-2,729
-9% -$131K
RARE icon
339
Ultragenyx Pharmaceutical
RARE
$2.66B
$1.19M 0.01%
23,269
-1,907
-8% -$96K
IWN icon
340
iShares Russell 2000 Value ETF
IWN
$14.6B
$1.14M 0.01%
9,365
-7,132
-43% -$893K
HVT icon
341
Haverty Furniture Companies
HVT
$443M
$1.11M 0.01%
55,019
-5,633
-9% -$121K
FANG icon
342
Diamondback Energy
FANG
$56.5B
$843K 0.01%
6,660
SPY icon
343
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$843K 0.01%
3,205
-8,504
-73% -$2.32M
AMGN icon
344
Amgen
AMGN
$224B
$803K 0.01%
4,713
-139,904
-97% -$25.7M
ACRS icon
345
Aclaris Therapeutics
ACRS
$871M
$735K 0.01%
41,946
-4,343
-9% -$92K
STE icon
346
Steris
STE
$23.2B
$672K 0.01%
7,193
-296
-4% -$26.9K
ACAD icon
347
Acadia Pharmaceuticals
ACAD
$5.07B
$591K 0.01%
+26,289
New +$728K
BNY
348
Bank of New York Mellon
BNY
$109B
$558K 0.01%
10,825
-291
-3% -$16.2K
BDX icon
349
Becton Dickinson
BDX
$49.4B
$493K 0.01%
2,330
-591
-20% -$129K
IWD icon
350
iShares Russell 1000 Value ETF
IWD
$84B
$464K 0.01%
3,865
-2,244
-37% -$280K

Similar funds

Rothschild & Co Asset Management US's Q1 2018 Portfolio in Review

As of Q1 2018, Rothschild & Co Asset Management US held 369 positions worth $8.99B, down 5.2% from $9.48B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Rothschild & Co Asset Management US withdrew a net $393M in Q1 2018, closing 16 positions and reducing 265 holdings. Its most notable exit was Celgene Corp, an estimated $36.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Rothschild & Co Asset Management US opened a new position in Air Products & Chemicals worth $56.4M.

  • Rothschild & Co Asset Management US's largest Q1 2018 buy was Air Products & Chemicals: 354,602 shares worth $56.4M.
  • Rothschild & Co Asset Management US added most to Verizon in Q1 2018, an estimated $38M increase.
  • Rothschild & Co Asset Management US's biggest Q1 2018 reduction was WestRock Company, cutting an estimated $31M.
  • Rothschild & Co Asset Management US fully exited Celgene Corp in Q1 2018, selling an estimated $36.2M.
  • Rothschild & Co Asset Management US's ten largest holdings make up 11% of its $8.99B portfolio in Q1 2018.
  • Rothschild & Co Asset Management US opened 24 new positions and closed 16 in Q1 2018.
  • Rothschild & Co Asset Management US's portfolio value fell 5.2% quarter-over-quarter to $8.99B.

Based on Rothschild & Co Asset Management US's 13F filing for Q1 2018, filed 8 May 2018.